Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N′-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent

Add time:08/30/2019    Source:sciencedirect.com

N-(2-Benzofuranylmethyl)-N′-[4-(2-fluoroethoxy)benzyl]piperazine (6, σ1 Ki = 2.6 nM) was radiolabeled with fluorine-18 to provide a potential σ1 receptor radioligand for use in positron emission tomography (PET). Radiofluorination of the appropriate tosylate precursor furnished [18F]6 with a specific activity of 45 GBq/μmol, in an average radiochemical yield of 18% and greater than 98% radiochemical purity. MicroPET imaging in Papio hamadryas baboon brain revealed [18F]6 uptake consistent with σ receptor distribution, and specificity for σ receptors was demonstrated in a haloperidol pre-treated animal. [18F]6 possesses suitable properties for PET imaging of σ1 receptors, and further investigation of this σ1 receptor tracer is warranted.

We also recommend Trading Suppliers and Manufacturers of 2-(2-FLUOROETHOXY)-BENZALDEHYDE (cas 132838-14-3). Pls Click Website Link as below: cas 132838-14-3 suppliers

Prev:Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography
Next:Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging)